Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Òåðàïèÿ > Ôîðóì äëÿ îáùåíèÿ âðà÷åé-òåðàïåâòîâ

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #16  
Ñòàðûé 04.12.2006, 15:38
Àâàòàð äëÿ Straus
Straus Straus âíå ôîðóìà ÂÐÀ×
Êàíäèäàò â âåòåðàíû ôîðóìà
      
 
Ðåãèñòðàöèÿ: 15.05.2004
Ãîðîä: ßðîñëàâëü
Ñîîáùåíèé: 1,103
Ïîáëàãîäàðèëè 2 ðàç(à) çà 2 ñîîáùåíèé
Straus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ìî÷åâèíó è êðåàòèíèí íàäî ñ÷èòàòü â âåñîâûõ åäèíèöàõ. Ò.å. êðåàòèíèí â ìã\ë èëè ìã%, ìî÷åâèíó òàêæå, ïðè÷åì èìååòñÿ â âèäó íå ìî÷åâèíà , à àçîò ìî÷åâèíû (íà êîòîðûé èç ìîëÿðíîé ìàññû 60 ïðèõîäèòñÿ ëèøü 28). Äëÿ ïåðåñ÷åòà ìèêðîìîëåé êðåàòèíèíà â ìã%, íåîáõîäèìî ìêìîëè ðàçäåëèòü íà 88,4.
 ñóõîì îñòàòêå èìååò ñëåäóþùåå (îïóñêàþ ìàòåìàòèêó) è äàþ êîíå÷íûé âûâîä. Åñëè êðåàòèíèí 492 ìêìîëü, à ìî÷åâèíà 17 ììîëü, òî àçîò ìî÷åâèíû â ìã% : 17,*2,8=47,6. Êðåàòèíèí â ìã% : 492:88,4=5,56. Ñîîòíîøåíèå 47,6 : 5,56 = 8,56. Ò.å. àçîòåìèÿ íå ÿâëÿåòñÿ ïðåðåíàëüíîé.
Ñîîòâåòñòâåííî äàëåå íóæíî îöåíèâàòü äèíàìèêó, ò.å. êàê ìåíÿåòñÿ ýòî ñîîòíîøåíèÿ íà ôîíå çàáîëåâàíèÿ, è, åñëè êîýôôèöèåíò ðåçêî íàðàñòàåò, òî ìû èìååì êðîìå ñîáñòâåííî ÕÏÍ åùå è ïðåðåíàëüíóþ àçîòåìèþ íà ôîíå ïàäåíèÿ ýôôåêòèâíîãî ÎÖÊ.

Êîììåíòàðèè ê ñîîáùåíèþ:
thorn îäîáðèë(à):
Îòâåòèòü ñ öèòèðîâàíèåì
  #17  
Ñòàðûé 05.12.2006, 10:14
Àâàòàð äëÿ Gilarov
Gilarov Gilarov âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 26.07.2001
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 7,196
Ïîáëàãîäàðèëè 713 ðàç(à) çà 691 ñîîáùåíèé
Gilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ïîðà î äèàëèçå äóìàòü...
Îòâåòèòü ñ öèòèðîâàíèåì
  #18  
Ñòàðûé 08.12.2006, 14:21
Àâàòàð äëÿ Straus
Straus Straus âíå ôîðóìà ÂÐÀ×
Êàíäèäàò â âåòåðàíû ôîðóìà
      
 
Ðåãèñòðàöèÿ: 15.05.2004
Ãîðîä: ßðîñëàâëü
Ñîîáùåíèé: 1,103
Ïîáëàãîäàðèëè 2 ðàç(à) çà 2 ñîîáùåíèé
Straus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
 ïðîäîëæåíèå òåìû. À êàê òðàêòîâàòü òàêîå: êðåàòèíèí 0,2 ìã%, ìî÷åâèíà 9,3 ììîëü\ë. (ôîðìàëüíî êîýôôèöèåíò îòíîøåíèé çàøêàëèâàåò çà 100 ?!), íàòðèé 115-120 ììîëü\ë., áåëîê 64 ã\ë.
Ïàöèåíò ñ òÿæåëîé ÕÑÍ íà ïî÷âå àîðòàëüíîãî ïîðîêà. Èñõîäíî çà íåäåëþ äî ýòîãî êðåàòèíèí áûë 1,8 ìã%, ãèïîíàòðèåìèÿ âî âñåõ àíàëèçàõ. Èçíà÷àëüíî áûë «ñóõîé», íî çàòåì ïîñòåïåííî îòåê. Òàê æå â ïðîöåññå «ëå÷åíèÿ» â îòäåëåíèè ïîÿâèëàñü æåëòóõà ñ áèëèðóáèíîì ê íàñòîÿùåìó ìîìåíòó 160 ìêìîëü\ë., òðàíñàìèíàçû ïîâûøåíû â 5-10 ðàç, ùåëî÷íàÿ ôîñôàòàçà ïðàêòè÷åñêè íîðìàëüíàÿ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #19  
Ñòàðûé 08.12.2006, 14:48
Àâàòàð äëÿ thorn
thorn thorn âíå ôîðóìà ÂÐÀ×
Çàñëóæåííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 10.04.2003
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 782
Ïîáëàãîäàðèëè 15 ðàç(à) çà 15 ñîîáùåíèé
thorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Straus
À êàê òðàêòîâàòü òàêîå: êðåàòèíèí 0,2 ìã%, ìî÷åâèíà 9,3 ììîëü\ë. (ôîðìàëüíî êîýôôèöèåíò îòíîøåíèé çàøêàëèâàåò çà 100 ?!), íàòðèé 115-120 ììîëü\ë...
ß áû ñíà÷àëà ïåðåïðîâåðèë êðåàòèíèí... Ãèïîíàòðèåìèÿ òèïè÷íà äëÿ òÿæåëîé ÕÑÍ + ìîæåò ïîëó÷àòü äèóðåòèêè (ãèïîòèàçèä). ×òî ñ ïå÷åíüþ - ìîæíî òîëüêî ãàäàòü: áûëà ëè ãèïîòåíçèÿ (èøåìèÿ ïå÷åíè)? ïðåïàðàòû? èñõîäíî ÷òî ñ ïå÷åíüþ áûëî (öèððîç âèðóñíûé, àëêîãîëüíûé)?
Îòâåòèòü ñ öèòèðîâàíèåì
  #20  
Ñòàðûé 08.12.2006, 17:08
Àâàòàð äëÿ Straus
Straus Straus âíå ôîðóìà ÂÐÀ×
Êàíäèäàò â âåòåðàíû ôîðóìà
      
 
Ðåãèñòðàöèÿ: 15.05.2004
Ãîðîä: ßðîñëàâëü
Ñîîáùåíèé: 1,103
Ïîáëàãîäàðèëè 2 ðàç(à) çà 2 ñîîáùåíèé
Straus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåStraus ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò thorn
ß áû ñíà÷àëà ïåðåïðîâåðèë êðåàòèíèí... Ãèïîíàòðèåìèÿ òèïè÷íà äëÿ òÿæåëîé ÕÑÍ + ìîæåò ïîëó÷àòü äèóðåòèêè (ãèïîòèàçèä). ×òî ñ ïå÷åíüþ - ìîæíî òîëüêî ãàäàòü: áûëà ëè ãèïîòåíçèÿ (èøåìèÿ ïå÷åíè)? ïðåïàðàòû? èñõîäíî ÷òî ñ ïå÷åíüþ áûëî (öèððîç âèðóñíûé, àëêîãîëüíûé)?
Ïåðåïðîâåðÿëè íåñêîëüêî ðàç, êîëåáàíèÿ 0,2 - 0,6. Êðèòè÷åñêîé ãèïîòåíçèè íå áûëî. Ìàðêåðû ãåïàòèòîâ âçÿëè ïîâòîðíî, âîäêè ìíîãî íå ïèë. Çà íåñêîëüêî äíåé äî äåáþòà æåëòóõè áûë íàçíà÷åí êîðäàðîí (çà÷åì, íå ñïðàøèâàéòå, èáî íå çíàþ).
Îòâåòèòü ñ öèòèðîâàíèåì
  #21  
Ñòàðûé 08.12.2006, 18:15
Àâàòàð äëÿ thorn
thorn thorn âíå ôîðóìà ÂÐÀ×
Çàñëóæåííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 10.04.2003
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 782
Ïîáëàãîäàðèëè 15 ðàç(à) çà 15 ñîîáùåíèé
thorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Straus
Çà íåñêîëüêî äíåé äî äåáþòà æåëòóõè áûë íàçíà÷åí êîðäàðîí
À àìèîäàðîí íà ïðè÷èíó ãåïàòèòà íå òÿíåò? Åñëè íàçíà÷àëñÿ ïàðåíòåðàëüíî, òî âïîëíå:
Öèòàòà:
Ratz Bravo AE, Drewe J, Schlienger RG, Krahenbuhl S, Pargger H, Ummenhofer W. Hepatotoxicity during rapid intravenous loading with amiodarone: Description of three cases and review of the literature. Crit Care Med. 2005 Jan;33(1):128-34

OBJECTIVE: Atrial fibrillation is the most common arrhythmia after cardiac surgery. Amiodarone can effectively prevent and control postoperative atrial and ventricular fibrillation. Acute hepatic damage after intravenous amiodarone, which can be fatal, is not well recognized. We describe three cases of acute hepatocellular injury after intravenous amiodarone administration in critically ill patients. Another 25 published cases and six cases reported to the Swiss Pharmacovigilance Center (Swissmedic) are discussed. DESIGN: This study consisted of a series of three case reports and review of the literature. SETTING:: This study was conducted at an operative critical care unit at the University Hospital Basel, Switzerland. PATIENTS: Three hemodynamically compromised patients after open heart surgery developed significant increases of transaminases (up to more than 100-fold of the upper limit of normal) shortly after the introduction of intravenous amiodarone. INTERVENTIONS AND MEASUREMENT: Cessation of intravenous amiodarone and of other potentially hepatotoxic drugs. RESULTS: Liver parameters significantly improved or returned to normal in all three patients, even after start of oral amiodarone in two patients. CONCLUSIONS: Amiodarone is a highly effective antiarrhythmic agent for the treatment and prevention of atrial and ventricular arrhythmias. Acute liver damage after intravenous amiodarone, possibly induced by the solubilizer polysorbate 80, is rare but potentially harmful. Amiodarone loading should therefore be adapted to the necessity of an immediate effect of the drug, and liver function should be monitored closely in critically ill patients. Oral maintenance therapy with amiodarone is possible, even in patients who developed liver disease during intravenous loading.
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 17:36.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.